Emergent Biosolutions
EBS
EBS
205 hedge funds and large institutions have $1.29B invested in Emergent Biosolutions in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 81 increasing their positions, 69 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more funds holding
Funds holding: 199 → 205 (+6)
0.98% more ownership
Funds ownership: 84.06% → 85.03% (+0.98%)
56% less call options, than puts
Call options by funds: $545K | Put options by funds: $1.24M
Holders
205
Holding in Top 10
4
Calls
$545K
Puts
$1.24M
Top Buyers
| 1 | +$22.4M | |
| 2 | +$19.4M | |
| 3 | +$17.9M | |
| 4 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$13.2M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.42M |
Top Sellers
| 1 | -$38M | |
| 2 | -$20.6M | |
| 3 | -$18.3M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$11.5M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$7.93M |